Siberry, George K <br/><br/>
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents.  [electronic resource] 

 -  The Pediatric infectious disease journal  May 2010 
 - 391-6 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1532-0987 
<br/><br/><label>Standard No.: </label>10.1097/INF.0b013e3181c38f3b  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Animals<br/>Antibodies, Bacterial--blood<br/>Child<br/>Diphtheria Toxoid--adverse effects<br/>Female<br/>HIV Infections--immunology<br/>Humans<br/>Male<br/>Meningococcal Infections--prevention & control<br/>Meningococcal Vaccines--adverse effects<br/>Microbial Viability--immunology<br/>Neisseria meningitidis, Serogroup A--immunology<br/>Neisseria meningitidis, Serogroup C--immunology<br/>Neisseria meningitidis, Serogroup W-135--immunology<br/>Neisseria meningitidis, Serogroup Y--immunology<br/>Surveys and Questionnaires<br/>United States<br/>Vaccines, Conjugate<br/>Young Adult